Global Clinical Trials Packaging Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Product Type (Vials , Blisters, Tubes, Bottles, Bags And Pouches, Others), By Material Type (Plastic, Glass, Metal, Paper), And By Geography - Forecasts From 2022 To 2027

  • Published : Sep 2022
  • Report Code : KSI061613487
  • Pages : 122

The clinical trials packaging market is estimated to grow at a CAGR of 5.40% to reach a market size of US$1.762 billion in 2027 from US$1.219 billion in 2020.

As there has been an increase in the number of orphan diseases or rare diseases affecting the population throughout the world, there has been a surge in the number of clinical trials being carried out worldwide. According to the statistics by the U.S. National Library OF Medicine, there are about 165,436 or 49% of the clinal studies and research being conducted in non-U.S. locations, 112,905 or 34% have been conducted in the U.S only, and 17,369 or 5% have been conducted in both U.S. and Non-U.S. locations. Lastly, the data for 39,492, or 12% of clinical trials in other locations, has not been reported. This calls for medicine and pharmaceutical manufacturers to come up with better formulations and competent compositions to control these diseases effectively. Consequently, it is putting a burden on the clinical trial packing companies and players to improve the state and the quality of their packing solutions as there is a critical issue involved in the packaging of sensitive drugs for clinical trials.

In addition, there are 4 phases in clinical trials, Phase I – Phase IV. Each phase requires a stringent packaging requirement.  In Phase 1, only a limited number of packs are sent, so packaging, called the primary packaging, must be good enough as the shelf life of the testing medicine is not much. More importantly, typical secondary packaging contains adequate labelling, which should include the name of the producer, the name of the medication and all of its ingredients, as well as the shelf life of each, as well as any necessary precautions to prevent tampering and counterfeiting. Then the primary packaged medicine, which is done using the cold form or thermoforms techniques, is out inside the secondary package, such as bottles, kits, or others with effective temperature control. Therefore, this has led to an increase in the demand for effective packing solutions by the market players and is a major driving factor in the market growth over the forecast period.

Furthermore, the market is anticipated to expand throughout the forecast period as a result of the rising need for safe, environmentally friendly, and hygienic packaging choices for healthcare products and eCommerce shipping.

The North American region to hold a considerable share over the forecast period due to increasing initiatives taken by the organizations, stringent regulations, and increasing investments

The North American region is expected to hold a significant share over the forecast period, which is attributable to the fact that the pharmaceutical and packing industry in the US is flourishing due to the increasing influx of investments. In addition, there are stringent guidelines in place for the packaging of the medicine to be used for clinical trials by organizations such as the FDA that must be complied with by the market players to minimize their losses and avoid the imposition of heavy penalties. 

Recent Developments

  • In February 2020, Almac Clinical Services announced the launch of its new solution called the “Label Approval Solution (LAS).” It is a fully compliant and vigilant system developed to manage the clinical labels effectively to adhere to the protocols. The LAS solution is aimed toward enabling the sponsors to gain access to the latest, upcoming technology, thereby streamlining the review and approval of label proofs, master text production, and label text localization. In addition, the solution can provide and optimize all the clinical label development processes by supporting the centralized technology- LAS.
  • Thermo Fisher Scientific launched new integrated commercial packaging and delivery services for cell and gene therapy in February 2022. The Patheon Commercial Packaging Services for Cell & Gene Therapies (CGT) is an all-inclusive solution that combines the GMP preservation, serialization, ultracold and cryogenic packaging, and international distribution that researchers require to support their logistics plans.
  • A renowned cGMP bio storage and pharmaceutical support services provider, Masy Systems Inc., was acquired by Alcami Corporation in December 2021, a leading pharma and biopharmaceutical contract development and manufacturing organization (CDMO).
  • To fulfil the expanding needs of the New England clinical supply market, PCI Pharma Services announced in November 2021 that a new Clinical Center of Excellence would be built in Bridgewater, Massachusetts. This facility would include clinical storage, distribution, and packaging.

COVID-19 Impact on Clinical Trials Packaging Market:

The COVID-19 pandemic outbreak has caused a significant increase in demand for medical device supplies and specific medications. Additionally, the COVID-19 situation has accelerated the contract packaging trend. As a result, there is a greater need for simple vial filling, folding cartons, and pressure-sensitive labels. The epidemic is expected to cause market participants to increase their manufacturing capabilities to meet the spike in demand. For instance, AzurRx BioPharma announced in May 2020 that it has entered into a distribution, packaging, and labelling agreement with Creapharm Clinical Supplies for the MS1819 clinical trial drug product. The market participants are also concentrating on the creation of novel materials to suit packaging needs during the pandemic.

Global Clinical Trials Packaging Market Scope:

Report Metric Details
 Market Size Value in 2020  US$1.219 billion
 Market Size Value in 2027  US$1.762 billion
 Growth Rate  CAGR of 5.40% from 2020 to 2027
 Base Year  2020
 Forecast Period  2022–2027
 Forecast Unit (Value)  USD Billion
 Segments Covered  Product Type, Material Type, And Geography
 Regions Covered  North America, South America, Europe, Middle East and Africa, Asia Pacific
 Companies Covered Piramal Pharma Solutions, Almac Group, Thermo Fisher Scientific Inc., Clinigen Clinical Supplies Management, Xerimis, PCI Services, SGS SA (Quay Pharma), Bilcare Ltd, Lonza, Rhenochem AG, Mikart, LLC
 Customization Scope  Free report customization with purchase



  • By Product Type
    • Vials
    • Blisters
    • Tubes
    • Bottles
    • Bags and Pouches
    • Others
  • By Material Type
    • Plastic
    • Glass
    • Metal
    • Paper
  • By Geography
    • North America
      • USA
      • Canada
      • Mexico
    • South America
      • Brazil
      • Argentina
      • Others
    • Europe
      • UK
      • Germany
      • France
      • Spain
      • Others
    • Middle East and Africa
      • Saudi Arabia
      • UAE
      • Others
    • Asia Pacific
      • Japan
      • China
      • India
      • South Korea
      • Indonesia
      • Taiwan
      • Others

Frequently Asked Questions (FAQs)

Q1. What are the growth prospects for the clinical trial packaging market?
A1. The global clinical trial packaging market is estimated to grow at a CAGR of 5.40% during the forecast period.

Q2. What will be the clinical trials packaging market size by 2027?
A2. The clinical trial packaging market is estimated to reach a market size of US$1.762 billion by 2027.

Q3. What is the size of the global clinical trial packaging market?
A3. Clinical Trials Packaging Market was valued at US$1.219 billion in 2020. 

Q4. Which region holds the largest market share in the clinical trials packaging market?
A4. The North American region holds a considerable share in the clinical trial packaging market due to increasing initiatives taken by the organizations, stringent regulations, and increasing investments.

Q5. What factors are anticipated to drive the clinical trials packaging market growth?
A5. The clinical trials packaging market is anticipated to expand as a result of the rising need for safe, environmentally friendly, and hygienic packaging choices for healthcare products and eCommerce shipping.

1. Introduction
1.1. Market Overview
1.2. COVID-19 Scenario
1.3. Market Definition
1.4. Market Segmentation

2. Research Methodology
2.1. Research Data
2.2. Assumptions

3. Executive Summary
3.1. Research Highlights

4. Market Dynamics
4.1. Market Drivers
4.2. Market Restraints
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis

5. Clinical Trials Packaging Market Analysis, by Product Type 
5.1. Introduction
5.2. Vials 
5.3. Blisters
5.4. Tubes
5.5. Bottles
5.6. Bags and Pouches
5.7. Others

6. Clinical Trials Packaging Market Analysis, by Material Type 
6.1. Introduction
6.2. Plastic
6.3. Glass
6.4. Metal
6.5. Paper

7. Clinical Trials Packaging Market Analysis, by Geography
7.1. Introduction
7.2. North America
7.2.1. United States
7.2.2. Canada
7.2.3. Mexico
7.3. South America
7.3.1. Brazil
7.3.2. Argentina
7.3.3. Others
7.4. Europe
7.4.1. UK
7.4.2. Germany
7.4.3. France
7.4.4. Spain
7.4.5. Others
7.5. Middle East and Africa 
7.5.1. Saudi Arabia
7.5.2. UAE
7.5.3. Others
7.6. Asia Pacific
7.6.1. Japan
7.6.2. China
7.6.3. India
7.6.4. South Korea
7.6.5. Indonesia
7.6.6. Taiwan
7.6.7. Others

8. Competitive Environment and Analysis
8.1. Major Players and Strategy Analysis
8.2. Emerging Players and Market Lucrativeness
8.3. Mergers, Acquisitions, Agreements, and Collaborations
8.4. Vendor Competitiveness Matrix

9. Company Profiles 
9.1. Piramal Pharma Solutions
9.2. Almac Group
9.3. Thermo Fisher Scientific Inc.
9.4. Clinigen Clinical Supplies Management 
9.5. Xerimis
9.6. PCI Services
9.7. SGS SA (Quay Pharma)
9.8. Bilcare Ltd
9.9. Lonza 
9.10. Rhenochem AG
9.11. Mikart, LLC

Piramal Pharma Solutions

Almac Group

Thermo Fisher Scientific Inc.

Clinigen Clinical Supplies Management


PCI Services

SGS SA (Quay Pharma)

Bilcare Ltd


Rhenochem AG

Mikart, LLC